AMR: ENABLE selects Mutabilis candidate
Efficacy of beta-lactam antibiotics, which represent 65% of the antibiotics sold throughout the world, is increasingly challenged in Gram-negative...
Biomarker identifies residual congestion in heart failure patients
The endothelial function marker bio-ADM of German diagnostics company SphingoTec GmbH reliably diagnosed tissue congestion and residual congestion in...
Magenta Therapeutics exercises ATAC licence option
Stem cell specialist Magenta Therapeutics (Cambridge, MA, USA) agreed to pay up to $85m in milestones for the rights to exclusively develop and...
BIOncoTech Therapeutics and MSD combine cancer drugs
The clinical collaboration aims at providing clincial Phase II evidence that Bioncotech Therapeutics’ RNA–based cancer lead BO-112 can improve the...
Azeria Therapeutics bags €37.3m in Series B financing round
Series A lead investor CRT Pioneer Fund co-financed the Series B financing round. Azeria said it will use the proceeds to develop its preclinical...
Astellas and Adaptimmune team up in CAR-T development
At J.P. Morgan conference, the British company announced that Astellas has agreed to co-develop and co-commercialize stem-cell derived allogeneic...
Sanofi buys Synthorx Inc for US$2.35bn
Sanofi SA‘s and Synthorx Inc's Boards approved the deal which forsees that Sanofi will acquire all of the outstanding shares of Synthorx for $68 per...